Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: A pilot series

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1249-1255

  Kongkam, Pradermchai ^a   Wagner, Dennis L ^a   Sherman, Stuart ^a   Fogel, Evan L ^a   Whittaker, Stephanie C ^a   Watkins, James L ^a   McHenry, Lee ^a   Lehman, Glen A ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; MORPHINE SULFATE; OCTREOTIDE; OMEGA CONOTOXIN MVIIA; OXYCODONE; SOMATOSTATIN; TRICYCLIC ANTIDEPRESSANT AGENT; NARCOTIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INFUSION PUMP; INTRACTABLE PAIN; INTRATHECAL NARCOTIC PUMP; LAMINECTOMY; LIQUORRHEA; LOW DRUG DOSE; MALE; PAIN ASSESSMENT; PANCREAS DIVISUM; PANCREAS RESECTION; PRIORITY JOURNAL; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; ABDOMINAL PAIN; DOSE RESPONSE; DRUG ADMINISTRATION; EPIDEMIOLOGY; HOSPITALIZATION; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; NARCOTICS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PANCREATITIS, CHRONIC; PILOT PROJECTS; QUALITY OF LIFE; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 66949160404     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.54     Document Type: Article

References (20)

1. Abdel Aziz AM, Lehman GA. Current treatment options for chronic pancreatitis. Curr Treat Options Gastroenterol 2007;10:355-68.
2. Jindal RM, Fineberg SE, Sherman S et al. Clinical experience with autologous and allogeneic pancreatic islet transplantation. Transplantation 1998;66:1836-41.
3. Verheijen R, Slappendel R, Jansen JB et al. Intrathecal administration of morphine and bupivacaine in the treatment of severe pain in chronic pancreatitis. Nederlands tijdschrift voor geneeskunde 1996;140:1410-2.
4. Hassenbusch SJ, Stanton-Hicks M, Covington EC et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995;10:527-43.
5. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage 1996;11:333-52.
6. Knight KH, Brand FM, McHaourab AS et al. Implantable intrathecal pumps for chronic pain: highlights and updates. Croat Med J 2007;48:22-34.
7. Hassenbusch SJ, Portenoy RK, Cousins M et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery - report of an expert panel. J Pain Symptom Manage 2004;27:540-63.
8. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999;116:1132-40.
9. Fasanella KE, Davis B, Lyons J et al. Pain in chronic pancreatitis and pancreatic cancer. Gastroenterol Clin North Am 2007;36:335-64, ix.
10. Gilmer-Hill HS, Boggan JE, Smith KA et al. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer. Surg Neural 1999;51:6-11.
11. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol 2001;55:79-86; discussion 86-8.
12. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004;109:242-9.
13. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-67.
14. Jensen MK, Thomsen AB, Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain (London, England) 2006;10: 423-33.
15. Aldrete JA, Couto da Silva JM. Leg edema from intrathecal opiate infusions. Eur J Pain (London, England) 2000;4:361-5.
16. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-300; discussion 300-1.
17. Paice JA, Penn RD, Short S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11: 71-80.
18. Anderson VC, Cooke B, Burchiel KJ. Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study. Pain Med (Maiden, Mass) 2001;2:287-97.
19. Bailey PL, Rhondeau S, Schafer PG et al. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology 1993;79:49-59; discussion 25A.
20. Boviatsis EJ, Kouyialis AT, Boutsikakis I et al. Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien) 2004;146:463-7.